Latest KFF Health News Stories
KFF Health News and California Healthline staffers made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Being Black has always been dangerous for pregnant women and infants in the South. And researchers say things are continuing to move in the wrong direction.
Sensing that Republicans are walking into a political minefield by threatening once again to repeal the Affordable Care Act, the Biden administration is looking to capitalize by rolling out a series of initiatives aimed at high drug prices and other consequences of “corporate greed in health care.” Meanwhile, the Supreme Court hears a case that could determine when and how much victims of the opioid crisis can collect from Purdue Pharma, the drug company that lied about how addictive its drug, OxyContin, really was. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Rachana Pradhan of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann of KFF Health News’ sister podcast, “An Arm and a Leg,” about his investigation into hospitals suing their patients over unpaid bills.
Los consumidores estadounidenses pagan algunos de los precios más altos del mundo por medicamentos de marca. En Canadá, el gobierno controla los precios.
Recogen de centros de salud, residentes, farmacias o prisiones los medicamentos sin abrir y sin caducar que se acumulan cuando los pacientes son dados de alta, cambian de medicina o mueren, y los redistribuyen a pacientes vulnerables.
Casi la mitad de los pacientes hispanos, los Indio americanos y los nativos de Alaska sienten que no se los respeta.
As open enrollment ends, many people are tuning out. They could wind up with a surprise next year: higher costs and less access to health care providers.
Obamacare had its moment, but not until the faceoff’s final minutes. Front-runner Donald Trump again was not on the debate stage, leaving the other Republican presidential hopefuls to slug it out to break through and gain voters’ attention.
Native American leaders see bison herds and ancestral gardens as ways to bring healthy eating to their people.
Colorado officials say they haven’t been able to stand up a program to import drugs from Canada because of drugmaker opposition — and the Biden administration’s inaction.
More than 2 million people a year have been sent notices that Social Security overpaid them and demanding they repay the money. That’s twice as many as the head of Social Security disclosed at a congressional hearing in October.
Long-term care options in the U.S. are costly, complex, and often inadequate. KFF Health News’ Jordan Rau and Reed Abelson of The New York Times host a Zoom panel to explore the challenges of providing — and affording — care.
KFF Health News gives readers a chance to comment on a recent batch of stories.
Peer-to-peer efforts can meet a clear need among students whose colleges may not make sexual health products accessible or affordable.
The regulatory proposal was announced Nov. 15 and is likely one of the last major ACA policy efforts of the president’s first term.
States and counties look to expand programs that accept donations of unused surplus drugs from places like nursing homes and hospitals and redistribute them to low-income and uninsured residents.
The Supreme Court heard arguments over whether the Sacklers, the family behind Purdue Pharma — which marketed OxyContin — could claim immunity from future lawsuits without claiming bankruptcy.
“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week.
Colorado’s leaders had grand plans to import cheaper medicines from Canada, after the Trump administration issued rules in 2020 allowing states to try it. But officials in Denver say they’ve been stymied by opposition from drugmakers — as well as the Biden administration’s inaction on the policy. That’s according to a Dec. 1 report we […]
The FDA and the manufacturer were alerted to Profemur titanium hips breaking inside U.S. patients as of 2005. It took 15 years to recall the devices. Many fractures could have been avoided.